The Growing Synergy Between AI and Genomics: Revolutionizing Medicine and Beyond

The Artificial Intelligence in Genomics Market is projected to grow to $6.22 billion by 2029, with a compound annual growth rate (CAGR) of 42.8% between 2022 and 2029.

Genomics involves analyzing, sequencing, and mapping genomes, providing insights into the function and structure of genes. The role of AI in genomics is expanding, particularly in variant calling, genome annotation, and genetic diagnosis. As technology enhances the efficiency and cost-effectiveness of whole genome mapping, companies are investing heavily in genomics for applications such as drug discovery, diagnostics, and precision medicine.

Download Sample Copy Here: https://www.meticulousresearch.com/download-sample-report/cp_id=5345 

Applications of Genomics Across Industries

The study of genomics is not limited to healthcare; its applications span medicine, biotechnology, agriculture, and even social sciences. The use of AI in genomics has accelerated over recent years. According to the National Human Genome Research Institute in 2021, the volume of data generated by genomics could reach 2–40 exabytes in the next decade. The increasing complexity of biological data, such as DNA sequencing, necessitates the use of AI tools for data management, extraction, and analysis.

AI’s Role in Enhancing Genomic Research

AI tools significantly enhance the interpretability of genomic data, transforming it into actionable clinical information. These tools also play a critical role in developing targeted therapies tailored to specific patient populations. The integration of AI into genomics is driving innovation, and AI platform developers in this space are actively seeking funding to further advance their solutions.

Investments Fueling the AI-Genomics Synergy

In recent years, several companies have invested in AI-powered genomics solutions. For instance, in March 2022, Illumina Accelerator funded seven startups, including NonExomics, Inc., which is using AI to map drug targets from previously uncharacterized genome regions. Similarly, DNAnexus raised $200 million in 2022 to enhance its AI-driven genomics and multi-omics platform. SeqOne Genomics, a French biotech company, secured $23.66 million in January 2022 to develop AI-driven genomic analysis tools for personalized medicine. In July 2021, Deep Genomics raised $180 million to further its AI-powered therapeutics research.

Public and Private Funding for AI-Driven Genomics

The growth in AI and genomics is not just driven by private investments. Public organizations, such as the National Human Genome Research Institute, are also providing funding for AI and machine learning-based genomic research to address complex biomedical challenges. With increasing financial support and technological integration, the global AI in genomics market is projected to grow at a CAGR of 42.8%, reaching $6.22 billion by 2029, as stated in a Meticulous Research® report.

Browse In Depth : https://www.meticulousresearch.com/product/ai-in-genomics-market-5345 

Key Players

The report includes a competitive landscape based on an extensive assessment of the key strategic developments that led market participants to adopt over the past three years. The key players profiled in the global AI in genomics market report are Microsoft Corporation (U.S.), NVIDIA Corporation (U.S.), Deep Genomics Incorporated (Canada), Fabric Genomics, Inc. (U.S.), Data4Cure, Inc. (U.S.), Predictive Oncology Inc. (U.S.), Emedgene Technologies LTD (U.S.), Congenica Ltd. (U.K.), Tempus Labs, Inc. (U.S.), SOPHiA GENETICS SA (Switzerland), Illumina Inc. (U.S.), and BenevolentAI Limited. (U.K.).

Scope of the Report:

Artificial Intelligence in Genomics Market, by Offering

• Software
• Services

Artificial Intelligence in Genomics Market, by Delivery Mode

• On-premises
• Cloud & Web-Based Mode

Artificial Intelligence in Genomics Market, by Functionality

• Genome Sequencing
• Gene Editing
• Other Functionalities
  (Note: Other functionalities include pharmacogenomics and predictive gene testing.)

Artificial Intelligence in Genomics Market, by Application

• Drug Discovery & Development
• Precision Medicine
• Diagnostics
• Other Applications
  (Note: Other applications include agriculture, pharmacology, and animal health.)

Artificial Intelligence in Genomics Market, by End User

• Pharmaceutical & Biopharmaceutical Companies
• Academic & Research Institutes
• Other End Users
  (Note: Other end users include contract research organizations and agriculture companies.)

Artificial Intelligence in Genomics Market, by Geography

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest of Europe (RoE)
• Asia-Pacific (APAC)
  • China
  • Japan
  • India
  • Rest of APAC (RoAPAC)
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America (RoLA)
• Middle East & Africa

Buy Now : https://www.meticulousresearch.com/Checkout/40485578

About Meticulous Research®

Meticulous Research® is a leading provider of comprehensive market intelligence, offering actionable insights and analysis across various industries. Our reports empower businesses to make informed decisions, drive growth, and remain competitive in a rapidly evolving marketplace.

Contact:

Meticulous Market Research Pvt. Ltd.
1267 Willis St, Ste 200 Redding,
California, 96001, U.S.
USA: +1-646-781-8004
Europe : +44-203-868-8738
APAC: +91 744-7780008
Email- sales@meticulousresearch.com
Visit Our Website: https://www.meticulousresearch.com/
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research